Follow The Filings

PASG Passage Bio

Passage Bio earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by PASG's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PASG insider trades
  • $206K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Lynx1 Capital Management LP 10% owner, +1 joint filer
    Buy
    $206K 50,055 shares at $4.12 +8% to stake
    Traded Jun 25 Filed Jun 29
    ↗

Also filed in the last 12 months, not counted as buying or selling: 2 option exercises and 2 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
424B3 Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,1.02,3.02,5.01,5.02,7.01,8.01,9.01 Filing Doc
8-K 1.02 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.05 Filing Doc
8-K 7.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 1.02 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.